INK Edge

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
JOIN THE CLUB
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
GO AD-FREE

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you downgrade to Basic or cancel with-in 10 days of first subscribing, we will refund your payment upon request. Immediately after downgrading or cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Bausch Health Companies (T:BHC) has notable insider buying

Updated Thursday Mar 14, 2019 02:32 AM EDT

Christina Ackermann, a Senior Officer, acquired 6,819 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $215,632 investment into the company's shares and an account share holdings change of greater than 100%.

Thomas Appio, a Senior Officer, acquired 7,387 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $233,593 investment into the company's shares and an account share holdings change of 14.8%.

Osama Eldessouky, a Senior Officer, acquired 3,551 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $112,291 investment into the company's shares and an account share holdings change of 27.3%.

Joseph Gordon, a Senior Officer, acquired 4,546 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $143,755 investment into the company's shares and an account share holdings change of 37.1%.

Paul Herendeen, CFO, acquired 19,889 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $628,935 investment into the company's shares and an account share holdings change of 20.4%.

Mark McKenna, a Senior Officer, acquired 2,841 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $89,839 investment into the company's shares and an account share holdings change of greater than 100%.

Joseph Papa, CEO and Director, acquired 37,884 Common Shares on a direct ownership basis at a price of $23.560USD through an exercise of rights on March 8th, 2019. This represents a $1,197,977 investment into the company's shares and an account share holdings change of 9.3%.

Bausch Health Companies is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
Sunny
Sunny
Sunny
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Bausch Health Companies Inc. (BHC)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $BHC.CA

  • No tweets found

Stocktwits